The FinTech Hub
Source: Live Mint Sai Life Sciences IPO: The initial public offering (IPO) of Sai Life Sciences Ltd ends today. The IPO opened for subscription on December 11 has been fully subscribed so far. Sai Life Sciences IPO is a book-built issue worth ₹3,042.62 crore and the shares are being sold at a price band of…
Source: Live Mint IPOs this week: India’s primary market will witness intense action as three new mainboard initial public offerings (IPOs) will open for bidding on Wednesday, December 11, 2024. Investors will be busy tracking the new issues for day-by-day subscription status, grey market premiums (GMPs), and the key dates to get the desired allotment….
Source: Live Mint TPG-backed Sai Life Sciences IPO is scheduled to open for subscription tomorrow (Wednesday, December 11). The firm is a contract research, development, and manufacturing organisation (CRDMO) that focuses on innovation. Backed by the private equity giant TPG Capital, it provides comprehensive services throughout the entire drug discovery, development, and manufacturing process for…
Source: Live Mint IPOs this week: The primary market is set to remain active next week, with five mainboard companies and six SME companies preparing to launch their initial public offerings (IPOs). Ranging from fintechs to supermarket chains, these mainboard IPOs are expected to collectively raise over ₹19,000 crore, reflecting strong investor interest across diverse…
Source: Live Mint The initial public offering (IPO) of Sai Life Sciences, a prominent player in small-molecule drug development and manufacturing, is scheduled to open on Wednesday, December 11, 2024, and close on Friday, December 13, 2024. The IPO consists of a fresh issue worth ₹950 crore and an offer for sale (OFS) of 3.81…
